The Technical Analyst
Select Language :
Check Cap Ltd [CHEK]

Exchange: NASDAQ Sector: Healthcare Industry: Diagnostics & Research

Check Cap Ltd Price, Forecast, Insider, Ratings, Fundamentals & Signals

Check Cap Ltd is listed at the  Exchange

13.09% $3.11

America/New_York / 28 mar 2024 @ 16:00


FUNDAMENTALS
MarketCap: 18.19 mill
EPS: -3.01
P/E: -1.030
Earnings Date: Mar 28, 2024
SharesOutstanding: 5.85 mill
Avg Daily Volume: 0.253 mill
RATING 2024-03-28
B
Neutral
RATINGS
Rating CashFlow: Neutral
Return On Equity: Sell
Return On Asset: Neutral
DE: Sell
P/E: Sell
Price To Book: Buy
QUARTER GROWTHS
2/223/224/221/232/233/23
Revenuen/an/an/an/an/an/a
Gr.Profitn/an/an/an/an/a
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -1.030 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.06x
Company: PE -1.030 | industry: PE 18.71
DISCOUNTED CASH FLOW VALUE
$0.551
(-82.28%) $-2.56
Date: 2024-03-29
Expected Trading Range (DAY)

$ 2.98 - 3.24

( +/- 4.21%)
ATR Model: 14 days

Forecast: 16:00 - $3.00

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $3.00
Forecast 2: 16:00 - $3.00
Forecast 3: 16:00 - $3.00
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $3.11 (13.09% )
Volume 0.434 mill
Avg. Vol. 0.253 mill
% of Avg. Vol 171.85 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Check Cap Ltd

Last 12 Months

Last 12 months chart data with high, low, open and close for Check Cap Ltd

RSI

Intraday RSI14 chart for Check Cap Ltd

Last 10 Buy & Sell Signals For CHEK

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Check Cap Ltd

CHEK

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.

Last 10 Buy Signals

Date Signal @
DASHUSDMar 29 - 08:57$39.61
NEXOUSDMar 29 - 08:531.331
BCHUSDMar 29 - 08:54$623.70
ROUTEUSDMar 29 - 08:504.37
OSMOUSDMar 29 - 08:451.380
BELUSDMar 29 - 08:440.982
DPIUSDMar 29 - 08:44$145.76
TIAUSDMar 29 - 08:3815.02
ETHUPUSDMar 29 - 08:3834.55
MPLUSDMar 29 - 08:3422.12

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.